Back to search

Article

Implementing Best Practises on Data Generation and Reporting of <i>Mycobacterium tuberculosis</i> Time Kill Assays: A Case Study of Standardized Protocol Within the ERA4TB Consortium

2022-07-08

Abstract excerpt

Tuberculosis (TB) is the deadliest infectious disease after COVID-19. The European Regimen Accelerator for Tuberculosis (ERA4TB) is a public-private partnership of more than 30 institutions with the objective to progress new anti-TB regimens into the clinic. Thus, robust and replicable results across independent laboratories are essential for reliable interpretation of treatment efficacy. Time-kill assays provide...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
36eb06a5-f38c-5d38-9656-3420ec4e85ed
DOI
10.2139/ssrn.4158008
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Implementing Best Practises on Data Generation and Reporting of <i>Mycobacterium tuberculosis</i> Time Kill Assays: A Case Study of Standardized Protocol Within the ERA4TB ConsortiumDOI 10.2139/ssrn.4158008
Validating a 14-drug microtitre plate containing bedaquiline and delamanid for large-scale research susceptibility testing of <i>Mycobacterium tuberculosis</i>Semantic proximity
Epidemiological cutoff values for a 96-well broth microdilution plate for high-throughput research antibiotic susceptibility testing of <i>M. tuberculosis</i>Semantic proximity
Rapidly and reproducibly building a comprehensive catalogue of resistance-associated variants for <i>M. tuberculosis</i>Semantic proximity
Reference Set of <i>Mycobacterium tuberculosis</i> Clinical Strains: A tool for research and product developmentSemantic proximity
Systematic measurement of combination drug landscapes to predict <i>in vivo</i> treatment outcomes for tuberculosisSemantic proximity
Antibiotic dose-response curves can measure antibiotic activity against <i>Mycobacterium abscessus</i> and <i>Mycobacterium peregrinum</i>Semantic proximity
The Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosis.Semantic proximity
Epidemiological cut-offs for Sensititre susceptibility testing of Mycobacterium tuberculosis: interpretive criteria cross validated with whole genome sequencingSemantic proximity
Strain diversity drives heterogeneous responses to tuberculosis combination therapySemantic proximity
Guidance for Studies Evaluating the Accuracy of Rapid Tuberculosis Drug-Susceptibility TestsSemantic proximity
Amoxicillin/clavulanate in combination with rifampicin/clarithromycin is bactericidal against <i>Mycobacterium ulcerans</i>Semantic proximity
Antibiotic lethality dictates mycobacterial infection outcomesSemantic proximity
Select a neighboring publication to make it the new centre.